Vaxcyte Stock Market Value
| PCVX Stock | USD 89.40 1.01 1.14% |
| Symbol | Vaxcyte |
Vaxcyte Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxcyte. If investors know Vaxcyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxcyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.60) | Return On Assets (0.15) | Return On Equity (0.21) |
The market value of Vaxcyte is measured differently than its book value, which is the value of Vaxcyte that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxcyte's value that differs from its market value or its book value, called intrinsic value, which is Vaxcyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxcyte's market value can be influenced by many factors that don't directly affect Vaxcyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxcyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxcyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxcyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vaxcyte 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vaxcyte's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vaxcyte.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Vaxcyte on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Vaxcyte or generate 0.0% return on investment in Vaxcyte over 30 days. Vaxcyte is related to or competes with Lyra Therapeutics, Hookipa Pharma, SAB Biotherapeutics, Cadrenal Therapeutics,, Monopar Therapeutics, Spero Therapeutics, and Coherus BioSciences. Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacte... More
Vaxcyte Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vaxcyte's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vaxcyte upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.48 | |||
| Information Ratio | 0.0299 | |||
| Maximum Drawdown | 42.81 | |||
| Value At Risk | (4.09) | |||
| Potential Upside | 3.16 |
Vaxcyte Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxcyte's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vaxcyte's standard deviation. In reality, there are many statistical measures that can use Vaxcyte historical prices to predict the future Vaxcyte's volatility.| Risk Adjusted Performance | 0.048 | |||
| Jensen Alpha | 0.3479 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0603 | |||
| Treynor Ratio | (0.25) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaxcyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vaxcyte Backtested Returns
Vaxcyte appears to be very steady, given 3 months investment horizon. Vaxcyte owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0539, which indicates the firm had a 0.0539% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vaxcyte, which you can use to evaluate the volatility of the company. Please review Vaxcyte's Coefficient Of Variation of 1929.65, semi deviation of 2.22, and Risk Adjusted Performance of 0.048 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vaxcyte holds a performance score of 4. The entity has a beta of -1.0, which indicates possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Vaxcyte are expected to decrease slowly. On the other hand, during market turmoil, Vaxcyte is expected to outperform it slightly. Please check Vaxcyte's treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to make a quick decision on whether Vaxcyte's existing price patterns will revert.
Auto-correlation | 0.79 |
Good predictability
Vaxcyte has good predictability. Overlapping area represents the amount of predictability between Vaxcyte time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vaxcyte price movement. The serial correlation of 0.79 indicates that around 79.0% of current Vaxcyte price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 53.28 |
Vaxcyte lagged returns against current returns
Autocorrelation, which is Vaxcyte stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vaxcyte's stock expected returns. We can calculate the autocorrelation of Vaxcyte returns to help us make a trade decision. For example, suppose you find that Vaxcyte has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vaxcyte regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vaxcyte stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vaxcyte stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vaxcyte stock over time.
Current vs Lagged Prices |
| Timeline |
Vaxcyte Lagged Returns
When evaluating Vaxcyte's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vaxcyte stock have on its future price. Vaxcyte autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vaxcyte autocorrelation shows the relationship between Vaxcyte stock current value and its past values and can show if there is a momentum factor associated with investing in Vaxcyte.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.